Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
Want to see GLUE full AI Analyst Report?
Monte Rosa Therapeutics (GLUE) Ownership Overview
10.02% Insiders
12.36% Mutual Funds
57.08% Other Institutional Investors
15.61% ETFs
4.93% Public Companies and
Individual Investors
The ownership structure of Monte Rosa Therapeutics (GLUE) stock is a mix of institutional, retail, and individual investors. Approximately 85.05% of the company’s stock is owned by Institutional Investors, 10.02% is owned by Insiders, and 4.93% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 15, 2026 | xxxxxxxxxxxxx | $141120 | |
Apr 10, 2026 | xxxxxxxxxxxxx | $103398 | |
Mar 05, 2026 | xxxxxxxxxxxxx | $2496 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $464848 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1036350 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $5179480 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $52323831 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $25590673 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,692,298 | Insider | 9.11% | 139,615,209 | |
| 4,345,736 | Institution | 5.14% | 78,875,108 | |
| 3,593,934 | Institution | 4.25% | 65,229,902 | |
| 3,180,780 | Institution | 3.77% | 57,731,157 | |
| 2,691,961 | Institution | 3.19% | 48,859,092 | |
| 2,391,976 | Institution | 2.83% | 43,414,364 | |
| 2,265,844 | Institution | 2.68% | 41,125,069 | |
| 2,078,649 | Institution | 2.46% | 37,727,479 | |
| 1,706,251 | Institution | 2.02% | 30,968,456 | |
| 1,555,664 | Institution | 1.84% | 28,235,302 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,391,976 | Institution | 2.83% | 43,414,364 | |
| 1,706,251 | Institution | 2.02% | 30,968,456 | |
| 1,186,156 | Institution | 1.40% | 21,528,731 | |
| 807,749 | Institution | 0.96% | 14,660,644 | |
| 548,387 | Institution | 0.65% | 9,953,224 | |
| 513,248 | Institution | 0.61% | 9,315,451 | |
| 421,524 | Institution | 0.50% | 7,650,661 | |
| 400,000 | Institution | 0.47% | 7,260,000 | |
| 395,481 | Institution | 0.47% | 7,177,980 | |
| 287,191 | Institution | 0.34% | 5,212,517 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,340,527 | Institution | 2.77% | 38,501,669 | |
| 2,151,138 | Institution | 2.55% | 43,582,056 | |
| 1,883,620 | Institution | 2.23% | 35,995,978 | |
| 1,412,876 | Institution | 1.67% | 27,000,060 | |
| 687,905 | Institution | 0.81% | 11,316,037 | |
| 521,128 | Institution | 0.62% | 9,958,756 | |
| 360,031 | Institution | 0.43% | 6,880,192 | |
| 341,901 | Institution | 0.40% | 6,533,728 | |
| 317,279 | Institution | 0.38% | 6,428,073 | |
| 298,223 | Institution | 0.35% | 6,041,998 |
FAQ
Who Owns Monte Rosa Therapeutics (GLUE)?
According to the latest TipRanks data, approximately 57.08% of the company's stock is held by institutional investors, 10.02% is held by insiders, and 4.93% is held by retail investors.
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 57.08% of Monte Rosa Therapeutics (GLUE) stock is held by institutional investors.
What percentage of Monte Rosa Therapeutics (GLUE) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.93% of Monte Rosa Therapeutics (GLUE) stock is held by retail investors.
Who owns the most shares of Monte Rosa Therapeutics (GLUE)?
Ali Behbahani owns the most shares of Monte Rosa Therapeutics (GLUE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.